Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Cancer | journal | 28.061 Q1 | 505 | 117 | 352 | 7724 | 8706 | 190 | 25.41 | 66.02 | 31.95 | |
2 | Journal of the National Cancer Institute | journal | 5.827 Q1 | 387 | 211 | 895 | 6598 | 4940 | 515 | 5.38 | 31.27 | 47.54 | |
3 | Leukemia | journal | 4.518 Q1 | 219 | 327 | 1094 | 11545 | 6958 | 701 | 6.24 | 35.31 | 40.81 | |
4 | Neuro-Oncology | journal | 4.098 Q1 | 163 | 195 | 630 | 7300 | 4728 | 496 | 7.33 | 37.44 | 36.35 | |
5 | European Journal of Cancer | journal | 3.839 Q1 | 245 | 353 | 1135 | 10352 | 7341 | 1017 | 6.12 | 29.33 | 40.92 | |
6 | Journal for ImmunoTherapy of Cancer | journal | 3.337 Q1 | 117 | 150 | 269 | 6491 | 1982 | 241 | 8.01 | 43.27 | 36.16 | |
7 | Molecular Cancer | journal | 3.274 Q1 | 196 | 164 | 449 | 11755 | 4299 | 434 | 10.87 | 71.68 | 41.42 | |
8 | Oncogene | journal | 3.127 Q1 | 370 | 462 | 1751 | 25124 | 11324 | 1743 | 6.42 | 54.38 | 40.79 | |
9 | Journal of Hematology and Oncology | journal | 2.960 Q1 | 144 | 135 | 425 | 8852 | 3345 | 417 | 8.51 | 65.57 | 44.16 | |
10 | Breast Cancer Research | journal | 2.874 Q1 | 175 | 151 | 397 | 6656 | 2483 | 380 | 5.59 | 44.08 | 52.65 | |
11 | British Journal of Cancer | journal | 2.848 Q1 | 272 | 434 | 1337 | 15122 | 7872 | 1246 | 5.28 | 34.84 | 43.19 | |
12 | Cell Death and Disease | journal | 2.310 Q1 | 164 | 1137 | 1499 | 56732 | 8763 | 1390 | 5.61 | 49.90 | 43.20 | |
13 | Prostate Cancer and Prostatic Diseases | journal | 2.200 Q1 | 78 | 71 | 188 | 2839 | 836 | 187 | 4.94 | 39.99 | 27.63 | |
14 | Endocrine-Related Cancer | journal | 1.985 Q1 | 146 | 157 | 400 | 11276 | 1991 | 366 | 4.54 | 71.82 | 42.46 | |
15 | Advances in Biological Regulation | journal | 1.882 Q1 | 69 | 54 | 107 | 4263 | 774 | 100 | 6.45 | 78.94 | 39.66 | |
16 | Carcinogenesis | journal | 1.820 Q1 | 223 | 157 | 414 | 7480 | 1872 | 408 | 3.93 | 47.64 | 41.02 | |
17 | Epigenomics | journal | 1.798 Q1 | 77 | 115 | 366 | 6453 | 1633 | 335 | 3.93 | 56.11 | 47.81 | |
18 | Journal of Experimental and Clinical Cancer Research | journal | 1.761 Q1 | 120 | 281 | 497 | 14600 | 2678 | 497 | 5.30 | 51.96 | 44.58 | |
19 | Molecular Therapy - Oncolytics | journal | 1.753 Q1 | 42 | 29 | 94 | 1314 | 488 | 93 | 5.79 | 45.31 | 42.06 | |
20 | Oral Oncology | journal | 1.508 Q2 | 137 | 302 | 691 | 10496 | 2508 | 568 | 3.30 | 34.75 | 34.34 | |
21 | Cancer Medicine | journal | 1.425 Q2 | 84 | 588 | 853 | 22359 | 3195 | 845 | 3.52 | 38.03 | 40.28 | |
22 | BMC Cancer | journal | 1.336 Q2 | 160 | 1277 | 2837 | 50327 | 9779 | 2833 | 3.11 | 39.41 | 41.88 | |
23 | Cancer Gene Therapy | journal | 1.233 Q2 | 99 | 30 | 196 | 1237 | 859 | 189 | 4.69 | 41.23 | 35.24 | |
24 | Cancer Cell International | journal | 1.180 Q2 | 80 | 212 | 314 | 9417 | 1223 | 314 | 3.49 | 44.42 | 42.01 | |
25 | Leukemia and Lymphoma | journal | 1.013 Q3 | 102 | 435 | 1551 | 13457 | 2484 | 943 | 1.57 | 30.94 | 42.20 | |
26 | Experimental Hematology and Oncology | journal | 0.988 Q3 | 42 | 33 | 95 | 1255 | 283 | 92 | 3.02 | 38.03 | 43.91 | |
27 | International Journal of Hyperthermia | journal | 0.988 Q3 | 98 | 237 | 336 | 9195 | 1209 | 314 | 3.47 | 38.80 | 31.65 | |
28 | Infectious Agents and Cancer | journal | 0.901 Q3 | 47 | 43 | 163 | 1777 | 410 | 163 | 2.61 | 41.33 | 46.53 | |
29 | Leukemia Research | journal | 0.892 Q3 | 96 | 205 | 589 | 6515 | 1314 | 562 | 2.00 | 31.78 | 42.83 | |
30 | Molecular and Cellular Oncology | journal | 0.877 Q3 | 37 | 126 | 465 | 1278 | 755 | 400 | 1.31 | 10.14 | 42.61 | |
31 | Japanese Journal of Clinical Oncology | journal | 0.806 Q3 | 95 | 181 | 589 | 4820 | 1252 | 542 | 2.01 | 26.63 | 21.13 | |
32 | Future Oncology | journal | 0.797 Q3 | 90 | 322 | 985 | 14461 | 1798 | 857 | 1.83 | 44.91 | 40.35 | |
33 | ecancermedicalscience | journal | 0.758 Q3 | 47 | 102 | 305 | 3451 | 599 | 305 | 1.87 | 33.83 | 39.31 | |
34 | Journal of Oral Pathology and Medicine | journal | 0.754 Q3 | 95 | 138 | 403 | 3872 | 869 | 387 | 2.06 | 28.06 | 45.54 | |
35 | Hematological Oncology | journal | 0.650 Q3 | 54 | 124 | 245 | 3800 | 382 | 218 | 1.68 | 30.65 | 43.34 | |
36 | Cancer Treatment and Research Communications | journal | 0.297 Q4 | 23 | 31 | 138 | 953 | 76 | 137 | 0.62 | 30.74 | 45.00 | |
37 | European Journal of Cancer, Supplement | journal | 0.256 Q4 | 29 | 0 | 10 | 0 | 9 | 10 | 9.00 | 0.00 | 0.00 | |
38 | Cancer Communications | journal | 0.124 Q4 | 79 | 74 | 221 | 3189 | 790 | 190 | 3.34 | 43.09 | 40.43 | |
39 | Cancer Reports | journal | 18 | 20 | 0 | 846 | 0 | 0 | 0.00 | 42.30 | 39.58 | ||
40 | Cell Death Discovery | journal | 58 | 124 | 249 | 5686 | 811 | 221 | 3.19 | 45.85 | 37.50 | ||
41 | ESMO Open | journal | 60 | 114 | 190 | 3028 | 649 | 146 | 3.42 | 26.56 | 34.62 | ||
42 | Molecular and Clinical Oncology | journal | 19 | 2 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 13.04 | ||
43 | npj Precision Oncology | journal | 36 | 27 | 1 | 1764 | 4 | 1 | 4.00 | 65.33 | 44.31 | ||
44 | Signal Transduction and Targeted Therapy | journal | 117 | 31 | 58 | 2821 | 350 | 54 | 6.03 | 91.00 | 39.70 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®